Lung Ventilation Support for Moderate ARDS

Ultra-Protective Lung Ventilation With Extracorporeal CO2 Removal for Moderate ARDS

Recruiting N/A Interventional Study
Acute Respiratory Distress Syndrome
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 – 100
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
230 (estimated)
Sponsor
University of Bologna · Other
Who this trial is looking for

This trial is looking for adults with moderate Acute Respiratory Distress Syndrome (ARDS) who are on mechanical ventilation. If eligible, you may receive a special type of lung support treatment to see if it helps you breathe better.

Are You a Good Fit for This Trial?
Rules you out Severe COPDChronic respiratory insufficiencyAcute brain injurySevere liver insufficiencyHeparin-induced thrombocytopeniaAcute coronary syndromeEnd-stage disease

You may be able to join if

  • I am 18 years or older
  • I have been on mechanical ventilation for 4 days or less
  • I have a specific level of oxygen in my blood after ventilation
  • I have low compliance of my respiratory system
  • I have a high ventilatory ratio
  • I have lung opacities
  • I have respiratory failure not due to heart issues
  • I have not improved with standard ventilation settings

You may not be able to join if

  • I am pregnant
  • I have very severe ARDS
  • I am expected to need mechanical ventilation for less than 2 days
  • I have severe COPD
  • I have chronic respiratory issues requiring home oxygen
  • I currently receive ECMO therapy
  • I have a severe brain injury
  • I have had burns covering more than 40% of my body

Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.

Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Acute respiratory distress syndrome (ARDS) accounts for 10% of all ICU admissions and for 23% of patients requiring mechanical ventilation (MV). Its hospital mortality remains high, ranging from 34% in mild forms up to 46% in severe cases. Positive pressure MV remains the cornerstone of management, but at the same time it can contribute to worsening and maintenance of the lung injury when excessiv…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Age ≥ 18 years * On invasive mechanical ventilation for ≤ 96 hours * Presence of all of the following conditions for ≤ 24 hours: 100 \< PaO2/FiO2 ≤ 200 after 12 hours of "standardized ventilation" with PEEP ≥ 5; compliance of the respiratory system ≤ 0.5 ml/cmH2O per kg PBW; v…
Contacts

Tommaso Tonetti, M.D.

+39-0512143268

tommaso.tonetti@unibo.it

CONTACT

Marco Ranieri, M.D.

+39-0512143268

m.ranieri@unibo.it

CONTACT